Back
Goldman Sachs Nasdaq-100 Premium Income ETF Vs. Corcept Therapeutics, Inc. Industry Stock Comparison
Buy
61
GPIQ
Goldman Sachs Nasdaq-100 Premium Income ETF
Last Price:
$52.88
Seasonality Move:
-1.01%
Sell
30
CORT
Corcept Therapeutics, Inc.
Last Price:
$34.79
Seasonality Move:
13.21%
Buy
61
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ)
is a Buy
Is Goldman Sachs Nasdaq-100 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs Nasdaq-100 Premium Income ETF [GPIQ] share price is $52.87. The Score for GPIQ is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Corcept Therapeutics, Inc. [CORT] share price is $34.80. The Score for CORT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPIQ Stock Price Chart
What is Goldman Sachs Nasdaq-100 Premium Income ETF's stock price today?
-
The Goldman Sachs Nasdaq-100 Premium Income ETF share price today is $52.87The current trend is moderately bearish and GPIQ is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics, Inc.'s stock price today?
-
The Corcept Therapeutics, Inc. share price today is $34.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CORT is experiencing slight selling pressure.
GPIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 49.26 | Sell |
| Chaikin Money Flow: | -1255183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.49 - 53.43) | Sell |
| Bollinger Bands (100): | (51.13 - 53.27) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.88 | Sell |
| Relative Strength Index (14 RSI): | 14.83 | Sell |
| Chaikin Money Flow: | -8077532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.63 - 90.59) | Sell |
| Bollinger Bands (100): | (69.66 - 84.14) | Sell |
GPIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.11 | Sell |
| 20-day SMA: | 53.01 | Sell |
| 50-day SMA: | 52.92 | Sell |
| 200-day SMA: | 49.6 | Buy |
| 8-day EMA: | 53.07 | Sell |
| 20-day EMA: | 52.95 | Sell |
| 50-day EMA: | 52.7 | Buy |
| 200-day EMA: | 50.67 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 75.24 | Sell |
| 20-day SMA: | 80.76 | Sell |
| 50-day SMA: | 77.62 | Sell |
| 200-day SMA: | 73.92 | Sell |
| 8-day EMA: | 69.79 | Sell |
| 20-day EMA: | 76.79 | Sell |
| 50-day EMA: | 77.19 | Sell |
| 200-day EMA: | 51.2 | Sell |
Goldman Sachs Nasdaq-100 Premium Income ETF Earnings Growth & GPIQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corcept Therapeutics, Inc. Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $3.04 per share.
Goldman Sachs Nasdaq-100 Premium Income ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||